Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors
Clinical trial NCT07028008 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07028008
- Sponsor
- Samsung Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-15
- Primary completion
- 2027-05-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.